Adapting Alzheimer’s Trials to a New Therapeutic Landscape: Early Detection and Operational Complexities
Adapting Alzheimer’s Trials to a New Therapeutic Landscape: Early Detection and Operational Complexities
Speakers:
Andreas Schreiner, MD
Senior Vice President, Medical Affairs, Neuroscience & Analgesia
Chris Foster, PhD
Senior Project Manager, Neuroscience